The last decade has seen immense changes in digital health, with increased use of electronic medical records, mobile applications, and wearable devices. During the COVID-19 pandemic, telehealth expanded access to care for millions of people and was a critical resource to meet the behavioral healthcare needs of individuals with mental health conditions and substance use disorders. Digital therapeutics (DTx) are health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a demonstrable positive therapeutic impact on a patient's health. DTx play an important role in facilitating care through technology.
This webinar will introduce the audience to a recently released SAMHSA advisory on DTx and the benefits of their use in behavioral health. The webinar will describe research, regulatory, and reimbursement implications for DTx, selection and implementation considerations, and issues related to equitable access of DTx in behavioral health. Through a roundtable format, the webinar will also highlight one state’s success in integrating DTx into its service provision.
